A. Avril

发表

Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases

J. Coindre, G. MacGrogan, M. Durand, 2004, Breast Cancer Research and Treatment.

Time for reappraisal of progesterone-receptor testing in breast cancer management.

I. de Mascarel, G. MacGrogan, S. Mathoulin-Pélissier, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa.

B. Bui, J. Coindre, A. Italiano, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective evaluation of quality of surgery in soft tissue sarcoma.

B. Bui, J. Coindre, G. Kantor, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.

G. MacGrogan, S. Mathoulin-Pélissier, L. Mauriac, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.

C. T. de Lara, J. Rodier, M. Velten, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic significance of Ki‐67 and topoisomerase IIα expression in infiltrating ductal carcinoma of the breast

J. Coindre, I. de Mascarel, G. MacGrogan, 1999, Breast Cancer Research and Treatment.

Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases.

J. Coindre, I. de Mascarel, G. MacGrogan, 1999, Breast cancer research and treatment.

Single-Session Radiofrequency Ablation of Bilateral Lung Metastases

V. Brouste, A. Avril, S. Ferron, 2012, CardioVascular and Interventional Radiology.

Analysis of 676 Cases of Ductal Carcinoma in Situ of the Breast From 1971 to 1995: Diagnosis and Treatment—the Experience of One Institute

M. Dilhuydy, B. Barreau, L. Mauriac, 2001, American journal of clinical oncology.

Sarcoma Lung Metastases Treated with Percutaneous Radiofrequency Ablation: Results from 29 Patients

V. Brouste, B. Bui, A. Italiano, 2011, Annals of Surgical Oncology.

Breast cancer and in vitro fertilization. About 32 cases.

L. Mauriac, A. Avril, E. Bussières, 1996, European journal of obstetrics, gynecology, and reproductive biology.

The role of radiotherapy in breast conserving treatment of ductal carcinoma in situ (DCIS): First results of EORTC trial 10853

I. Fentiman, R. Sylvester, P. Rouanet, 1998 .

Immunohistochemical determination of pS2 in invasive breast carcinomas: a study on 942 cases

J. Coindre, I. Soubeyran, M. Durand, 1995, Breast Cancer Research and Treatment.

Quality of surgery in soft tissue sarcoma: a single centre experience with the French Sarcoma Group (FSG) surgical system

B. Bui, J. Coindre, G. Kantor, 2005 .

[Breast cancer and hMG treatment: is there a relationship?].

L. Mauriac, F. Gaillard, A. Avril, 1995, Journal de gynecologie, obstetrique et biologie de la reproduction.

Number of residual nodules, better than size, defines optimal surgery in advanced epithelial ovarian cancer

G. MacGrogan, V. Picot, A. Floquet, 2003, International Journal of Gynecologic Cancer.

Retroperitoneal soft tissue sarcomas: A pilot study of intraoperative radiation therapy

B. Bui, J. Coindre, G. Kantor, 1996, Journal of surgical oncology.

[Angiosarcoma of the breast: 4 case reports and review of the literature].

A. Avril, E. Ventrillon, 1992, Revue francaise de gynecologie et d'obstetrique.

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.

L. Mauriac, A. Avril, J. Dilhuydy, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

The association of interpleural ropivacaine and epidural following major thoracic surgery: a randomised clinical trial investigating pharmocokinetics and benefits.

S. Mathoulin-Pélissier, A. Avril, M. Molimard, 2013 .

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

J. Peterse, H. Bartelink, E. Rutgers, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases

J. Coindre, M. Durand, F. Bonichon, 1995, Breast Cancer Research and Treatment.

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853

J. Peterse, H. Bartelink, I. Fentiman, 2000, The Lancet.

[Male breast cancer: a review of 52 cases collected at the Institute Bergonié (Bordeaux, France) from 1980 to 2004].

I. de Mascarel, G. MacGrogan, L. Mauriac, 2008, Gynecologie, obstetrique & fertilite.

[Surgery of pulmonary metastasis from malignant melanoma. Results and criteria of surgical excision].

M. Avril, M. Delaunay, A. Avril, 1991, Annales de dermatologie et de venereologie.

Original Paper Obvious Peritumoral Emboli: an Elusive Prognostic Factor Reappraised. Multivariate Analysis of 1320 Node-negative Breast Cancers

G. MacGrogan, I. Soubeyran, V. Picot, 1998 .

Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers.

J. Coindre, I. de Mascarel, G. MacGrogan, 1998, European journal of cancer.

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer

J. Coindre, G. MacGrogan, S. Mathoulin-Pélissier, 2003, British Journal of Cancer.

A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases.

B. Bui, J. Coindre, C. T. de Lara, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Primary breast sarcoma. A retrospective study of 42 patients treated at the Bergonié Institute during a 32-year period].

B. Bui, J. Coindre, G. MacGrogan, 2004, Journal de gynecologie, obstetrique et biologie de la reproduction.

Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examinated by serial macroscopic sectioning: Practical considerations

J. Coindre, I. de Mascarel, G. MacGrogan, 2000, Breast Cancer Research and Treatment.

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS

A. Hart, I. Fentiman, E. Rutgers, 2002, British Journal of Cancer.

Ductal Carcinoma In Situ of the Breast: Influence of Age on Diagnostic, Therapeutic, and Prognostic Features. Retrospective Study of 812 Patients

V. Brouste, G. MacGrogan, L. Mauriac, 2011, Annals of Surgical Oncology.

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS).

G. MacGrogan, L. Mauriac, A. Floquet, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF+ tamoxifen in a single centre

M. Dilhuydy, L. Mauriac, M. Durand, 1988, Breast Cancer Research and Treatment.

[Prognostic significance of isolated local recurrences in breast cancer following mastectomy and axillary node excision. Apropos of 77 recurrences in 2362 patients].

J. Renaud-salis, L. Mauriac, M. Durand, 1986, Bulletin du cancer.

[First surgery followed by vaginal curietherapy in small-volume uterine cervix cancer: an alternative to the association of uterovaginal curietherapy and surgery].

A. Floquet, A. Avril, E. Bussières, 2002, Cancer Radiothérapie.

High dose folinic acid and 5‐fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer

Y. Bécouarn, P. Richaud, A. Avril, 1995, Cancer.

[Combination treatment of localised breast cancers with a high risk of metastatic disease. The results of a prospective controlled study (author's transl)].

M. Durand, B. Hoerni, P. Richaud, 1981, Journal de gynecologie, obstetrique et biologie de la reproduction.

[Results of 10 years of a randomized trial of neoadjuvant chemotherapy in breast cancers larger than 3 cm].

L. Mauriac, M. Durand, F. Bonichon, 1998, Chirurgie; memoires de l'Academie de chirurgie.

[Conservative loco-regional treatment of soft tissue sarcoma in adults after induction chemotherapy].

J. Coindre, P. Richaud, A. Avril, 1985, Presse medicale.

Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.

G. MacGrogan, L. Mauriac, M. Debled, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Functional outcome of laparoscopically transposed ovaries in the multidisciplinary treatment of cervical cancers. Analysis of risk factors].

A. Avril, L. Thomas, F. Lakdja, 1996, Journal de gynecologie, obstetrique et biologie de la reproduction.

A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases.

B. Bui, J. Coindre, G. Kantor, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The SENEX System : A Microcomputer-Based Expert System Built by Oncologists for Breast Cancer Management

M. Durand, F. Bonichon, A. Avril, 1987 .